Chronic Lymphocytic Leukemia
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | CD20 + | Chronic Lymphocytic Leukemia | Cyclophosphamide, Fludarabine, Rituximab | |
| FDA (1) | 17p deletion | Chronic Lymphocytic Leukemia | Ibrutinib |